Appointed Vice President and Chief Medical Officer the Radiopharmaceuticals Division in April 2022, bringing over 30 years of experience in medicine, cardiology, research, imaging and innovation in academic and pharmaceutical medicine to global healthcare.
Previously, Melda was Global Medical and Regulatory Affairs Executive Senior Director at Bracco Diagnostics and Research Professor at Saint Louis University Hospital Cardiology. She served as a key opinion leader in healthcare globally.